EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Effect of Vitamin D3, Omega-3 Fatty Acids, and Exercise on Serum Sclerostin Levels and Bone Turnover Markers

Elena Tsourdi iD, Stephanie Gängler, Melanie Kistler-Fischbacher, Martina Rauner, Bess Dawson-Hughes iD, E John Orav, Li-Tang Tsai, Wei Lang, John A Kanis, Robert Theiler, Andreas Egli, Heike A Bischoff-Ferrari und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae859 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Elena Tsourdi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, Technische Universität Dresden, 01307 Dresden, Germany. Hauptthemen laut MEDLINE: Cholecalciferol, Fatty Acids, Omega-3, Bone Remodeling, Bone Morphogenetic Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Seventh Framework Program of the European Commission, University of Zurich, DSM Nutritional Products.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Sclerostin inhibits canonical Wnt signaling, a pathway promoting bone formation. The effects of vitamin D3, omega-3 fatty acids (omega-3s), and exercise on serum sclerostin levels and bone metabolism are unclear.

Objective

To investigate the effects of 2000 IU/day vitamin D3, 1 g/day omega-3s, and a simple home-based strength exercise program (SHEP), alone or in combination, on serum sclerostin and bone turnover marker levels.

Methods

Sclerostin, procollagen type 1 N propeptide (P1NP) and C-terminal telopeptide (β-CTx) levels were predefined secondary outcomes of DO-HEALTH, a double blind, randomized controlled trial in healthy physically active older adults in 5 European countries. Outcome measures were changes in yearly serum sclerostin, P1NP, and β-CTx levels over 3 years, adjusted for age, sex, prior falls, study site, baseline body mass index, and baseline level of the respective outcome.

Results

A total of 1848 participants were included (mean age 74.8 ± 4.4 years, 58.9% women, 41.4% 25(OH)D < 20 ng/mL, 83.9% at least moderately physically active at baseline). Vitamin D3 and omega-3s supplementation alone did not change sclerostin levels significantly, while SHEP compared with control exercise (joint mobility) led to greater decrease in sclerostin levels (−1.56 pmol/L [−2.54, −0.58], P = .002). Omega-3s plus SHEP led to a greater decrease in sclerostin levels than no omega-3s/control exercise (−1.93 pmol/L [−3.31, −0.54], P = .007). For P1NP and β-CTx there were no significant effects for any of the individual treatments and treatment combinations.

Conclusion

In this 3-year prevention trial among largely vitamin D replete adults age 70 and older, SHEP alone or in combination with omega-3s reduced serum sclerostin levels, while vitamin D3 and omega-3s alone did not affect serum sclerostin levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholecalciferolFatty Acids, Omega-3Bone RemodelingBone Morphogenetic ProteinsExerciseHumansFemaleAgedAdaptor Proteins, Signal TransducingMaleGenetic MarkersDouble-Blind MethodBiomarkersAged, 80 and overProcollagenPeptide FragmentsPeptidesCollagen Type IDietary Supplements

Stichwörter der Autor:innen

C-terminal telopeptide (CTX)exerciseomega-3 fatty acidsprocollagen type 1 N propeptide (P1NP)sclerostinvitamin D3

Substanzen

SOST protein, humanAdaptor Proteins, Signal TransducingCholecalciferolFatty Acids, Omega-3Genetic MarkersBiomarkersBone Morphogenetic ProteinsProcollagenprocollagen Type I N-terminal peptidePeptide Fragments

Autor:innen und Institutionen

  • Department of Medicine III, Technische Universität Dresden, 01307 Dresden, Germany.
  • Center for Healthy Aging, Technische Universität Dresden, 01307 Dresden, Germany.
  • Centre on Aging and Mobility, Univearsity of Zurich, 8037 Zurich, Switzerland.
  • Department of Geriatrics and Aging Research, University of Zurich, 8006 Zurich, Switzerland.
  • Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, USA.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

ORCID-Profile: Elena Tsourdi, Bess Dawson-Hughes, Lorenz C Hofbauer

Förderung

  • Seventh Framework Program of the European Commission
  • University of Zurich
  • DSM Nutritional Products
  • Roche Diagnostics
  • NESTEC
  • Pfizer
  • Streuli

Zitieren

APA

Tsourdi, E., Gängler, S., Kistler-Fischbacher, M., Rauner, M., Dawson-Hughes, B., Orav, E. J., Tsai, L. T., Lang, W., Kanis, J. A., Theiler, R., Egli, A., Bischoff-Ferrari, H. A., & Hofbauer, L. C. (2025). Effect of Vitamin D3, Omega-3 Fatty Acids, and Exercise on Serum Sclerostin Levels and Bone Turnover Markers. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae859

Vancouver

Tsourdi E, Gängler S, Kistler-Fischbacher M, Rauner M, Dawson-Hughes B, Orav EJ, et al. Effect of Vitamin D3, Omega-3 Fatty Acids, and Exercise on Serum Sclerostin Levels and Bone Turnover Markers. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae859

BibTeX
@article{Tsourdi2025,
  author = {Tsourdi, Elena and Gängler, Stephanie and Kistler-Fischbacher, Melanie and Rauner, Martina and Dawson-Hughes, Bess and Orav, E John and Tsai, Li-Tang and Lang, Wei and Kanis, John A and Theiler, Robert and Egli, Andreas and Bischoff-Ferrari, Heike A and Hofbauer, Lorenz C},
  title = {Effect of Vitamin D3, Omega-3 Fatty Acids, and Exercise on Serum Sclerostin Levels and Bone Turnover Markers},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae859}
}
Kostenlos starten →